Atlas Trials

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Profile of MT101-5 in Healthy Volunteers

Clinical trial NCT05844787 · COMPLETED

Trial details

NCT number
NCT05844787
Sponsor
Mthera Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2022-07-11
Primary completion
2023-02-23
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.